Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.

    Møller P, Mæhle L, Engebretsen LF, Ludvigsen T, Jonsrud C, Apold J, Vabø A, Clark N.

    Hered Cancer Clin Pract. 2010 Jan 19;8(1):2.

    PMID:
    20180971
    [PubMed]
    Free PMC Article
    2.

    Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.

    Clin Cancer Res. 2002 Dec;8(12):3776-81.

    PMID:
    12473589
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

    Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA.

    J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706.

    PMID:
    17148771
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.

    Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, Velasco E, Chirivella I, Cardeñosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martínez E, Guillén C, Salazar R, San Román C, Antoniou AC, Urioste M, Benítez J.

    Clin Cancer Res. 2008 May 1;14(9):2861-9.

    PMID:
    18451254
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

    Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA.

    Am J Hum Genet. 2001 Mar;68(3):700-10. Epub 2001 Feb 15.

    PMID:
    11179017
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

    Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D.

    Am J Hum Genet. 1997 May;60(5):1059-67.

    PMID:
    9150153
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations.

    Marroni F, Aretini P, D'Andrea E, Caligo MA, Cortesi L, Viel A, Ricevuto E, Montagna M, Cipollini G, Federico M, Santarosa M, Marchetti P, Bailey-Wilson JE, Bevilacqua G, Parmigiani G, Presciuttini S.

    Eur J Hum Genet. 2004 Nov;12(11):899-906.

    PMID:
    15340362
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

    Heimdal K, Maehle L, Apold J, Pedersen JC, Møller P.

    Eur J Cancer. 2003 Oct;39(15):2205-13.

    PMID:
    14522380
    [PubMed - indexed for MEDLINE]
    9.
    10.

    Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

    Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR.

    J Natl Cancer Inst. 1999 Jun 2;91(11):943-9.

    PMID:
    10359546
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

    Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

    Am J Hum Genet. 2003 May;72(5):1117-30. Epub 2003 Apr 3. Erratum in: Am J Hum Genet. 2003 Sep;73(3):709.

    PMID:
    12677558
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.

    Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon SY, Taib NA, Thong MK, Yip CH, Teo SH.

    Breast Cancer Res. 2008;10(4):R59. Epub 2008 Jul 16.

    PMID:
    18627636
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

    Casey MJ, Bewtra C.

    Fam Cancer. 2004;3(3-4):265-81. Review.

    PMID:
    15516851
    [PubMed - indexed for MEDLINE]
    15.

    Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

    Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E.

    Int J Cancer. 2000 Jun 1;86(5):737-40.

    PMID:
    10797299
    [PubMed - indexed for MEDLINE]
    16.

    Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

    Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A.

    J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23.

    PMID:
    11504767
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

    Gynecol Oncol. 2005 May;97(2):457-67.

    PMID:
    15863145
    [PubMed - indexed for MEDLINE]
    18.

    BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.

    Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA.

    Am J Hum Genet. 2000 Apr;66(4):1259-72. Epub 2000 Mar 16.

    PMID:
    10739756
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan.

    Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA.

    Am J Hum Genet. 2002 Sep;71(3):595-606. Epub 2002 Aug 13.

    PMID:
    12181777
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.

    Breast Cancer Family Registry; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (Australasia); Ontario Cancer Genetics Network (Canada).

    Breast Cancer Res Treat. 2008 May;109(1):67-75. Epub 2007 Oct 31.

    PMID:
    17972172
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk